Counts Jon M, Astles J Rex, Tenover Fred C, Hindler Janet
University of Washington, Seattle, Washington 98121, USA.
J Clin Microbiol. 2007 Jul;45(7):2230-4. doi: 10.1128/JCM.00184-07. Epub 2007 May 23.
Laboratory practice in the preanalytical phase of antimicrobial susceptibility testing (AST) was evaluated in 102 hospital, reference, physician office-clinic, and public health laboratories in Washington state. Surveys were sent to evaluate (i) use of NCCLS/CLSI (formerly NCCLS) AST performance standards, (ii) technical competence in AST case studies, challenging knowledge of contemporary testing issues, and (iii) choice of antimicrobial agents to test for Streptococcus pneumoniae. Numerous deficiencies were identified in the survey: (i) initially only 40% of the laboratories surveyed used current NCCLS/CLSI AST performance standards, (ii) the rate of accurate responses for three different case studies ranged from 29% to 69%, and (iii) variation was noted in the choice of antimicrobials tested against invasive isolates of S. pneumoniae. These deficiencies could affect therapy and detection of antimicrobial resistance. Several educational programs were implemented to improve AST policies and practices, and a follow-up survey indicated that four intervention strategies were most effective: (i) regional technical workshops, (ii) National Laboratory Training Network teleconferences, (iii) use of the Centers for Disease Control and Prevention (CDC) CD-ROM on AST, and (iv) the CDC Multilevel Antimicrobial Susceptibility Testing Resource website. The interventions could be implemented more widely in the United States to improve AST knowledge and practices.
华盛顿州的102家医院、参考实验室、医师办公室诊所及公共卫生实验室接受了抗菌药物敏感性试验(AST)分析前阶段实验室操作的评估。开展调查以评估:(i)NCCLS/CLSI(原NCCLS)AST性能标准的使用情况;(ii)AST案例研究中的技术能力、对当代检测问题的知识考查;(iii)针对肺炎链球菌检测的抗菌药物选择。调查发现了诸多不足之处:(i)最初,仅40%接受调查的实验室使用当前的NCCLS/CLSI AST性能标准;(ii)针对三个不同案例研究的准确回答率在29%至69%之间;(iii)针对肺炎链球菌侵袭性分离株的抗菌药物检测选择存在差异。这些不足可能会影响治疗及抗菌药物耐药性的检测。实施了多项教育项目以改进AST政策及操作,一项后续调查表明四种干预策略最为有效:(i)区域技术研讨会;(ii)国家实验室培训网络电话会议;(iii)使用疾病控制与预防中心(CDC)关于AST的光盘;(iv)CDC多级抗菌药物敏感性试验资源网站。这些干预措施可在美国更广泛地实施,以提高AST知识及操作水平。